Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Toxicologic Pathology|September 14, 2016
Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and MouseBrian R Berridge, Vasanthi Mowat, Hirofumi Nagai, et al.Journal of Pharmaceutical Health Care and Sciences|December 1, 2022
Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective studyHirofumi Nagai, Tsutomu Shimada, Yoshimitsu Takahashi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
A novel ultra-thin bare metal stent (BMS): results from a worldwide registryDidier Blanchard, Gian Battista Danzi, Philip Urban, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trialBernard Chevalier, Patrick W Serruys, Sigmund Silber, et al.Stem Cell Reports|January 24, 2017
Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived CardiomyocytesTadahiro Shinozawa, Koki Nakamura, Masanobu Shoji, et al.Circulation. Cardiovascular Interventions|December 25, 2009
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2Bernard Chevalier, Sigmund Silber, Seung-Jung Park, et al.American Heart Journal|December 5, 2016
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohortsRobert W Harrison, Vaishnavi Radhakrishnan, Peter S Lam, et al.American Heart Journal|October 21, 2018
The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohortsRobert W Harrison, Vaishnavi Radhakrishnan, John C Allen, et al.Toxicologic Pathology|April 23, 2016
Characterizing "Adversity" of Pathology Findings in Nonclinical Toxicity Studies: Results from the 4th ESTP International Expert WorkshopXavier Palazzi, John E Burkhardt, Henri Caplain, et al.Pageof 2